Organigram’s Strong Q2 Growth and Strategic Moves
Company Announcements

Organigram’s Strong Q2 Growth and Strategic Moves

OrganiGram Holdings (TSE:OGI) has released an update.

Organigram Holdings Inc. reported a robust second quarter with a 21% growth in recreational net revenue, closing of significant funding rounds, and strategic U.S. investments potentially benefiting from federal regulatory shifts. The company solidified its market position with top rankings across various cannabis product categories in Canada and substantial international growth through new supply agreements and shipments. Organigram’s strong cash position and minimal debt set it apart as a leading licensed producer poised for strategic international expansions.

For further insights into TSE:OGI stock, check out TipRanks’ Stock Analysis page.


Price Change
S&P 500
Dow Jones
Nasdaq 100

Popular Articles